Intravenous immunoglobulin overtreatment in CIDP

Registry ID

EUCTR2013-005363-52

Source registry

EUCTR

Status

Ongoing

Phase

PHASE4

Sponsor

Department of Neurology, Academic Medical Center

Start date

2014-09-10

Last update

2026-08-16

Conditions

• Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

Summary

The primary objective is to determine whether subjects with CIDP are overtreated with maintenance IVIg treatment and to reduce overtreatment-associated subjects’ burden and health care costs.

Locations

• , , Netherlands

Related clinical trials

• An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Xembify versus Gamunex-C in Participants with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

View on source registry